CRF2 Agonist for the Treatment of Worsening Heart Failure

Clinical trial NCT06815471 · SUSPENDED

Trial details

NCT number: NCT06815471
Sponsor: Corteria Pharmaceuticals
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Worsening Heart Failure

Start date: 2025-08-07
Primary completion: 2026-12-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.